January 14, 2021

Precision Medicine Group Significantly Expands Cell and Gene Therapy Expertise with Acquisition of Project Farma

LEADING BIO-ENGINEERING AND MANUFACTURING SERVICES FIRM CATALYZES THE LAUNCH OF PRECISION’S CELL AND GENE THERAPY OFFERING—’PRECISION ADVANCE’—ADDRESSING THE UNIQUE CHALLENGES OF CELL & GENE THERAPY INNOVATORS, FROM DEVELOPMENT THROUGH COMMERCIALIZATION BETHESDA, MD—January 14, 2021—Precision Medicine Group (“PMG”) announced today it has acquired Project Farma, a patient-focused bioengineering services firm that […]
September 17, 2020

Precision nominated for “Best CRO” by OBN Awards

Precision for Medicine is excited to be named as one of three finalists for an OBN Award 2020 in the Best CRO category! Congratulations to our fellow finalists. The OBN Awards celebrate the UK’s most innovative life sciences companies. https://lnkd.in/dQK—x
May 17, 2020

Mark Clein, Co-Founder and CEO of Precision Medicine Group, delivers the keynote address for BioTrinity 2020

You can view his address at your convenience here. In the course of his presentation you will hear: The ways in which digital technology is transforming patient care and impacting clinical trials What new breakthroughs are on the horizon How precision medicine continues to advance and affect patient treatment and […]
May 1, 2020

How Precision is responding to COVID-19

Protecting our employees, continuing the important work of our clients Precision for Medicine, part of Precision Medicine Group’s global team of pharmaceutical and life science experts, is diligently monitoring and complying with the latest state, national, and international regulatory guidelines surrounding the COVID-19 pandemic commonly known as the “coronavirus.” While […]
April 21, 2020

Precision for Medicine Partners with Karyopharm Therapeutics to Initiate New Global Clinical Trial to Treat Patients with COVID-19

PRECISION FOR MEDICINE PARTNERS WITH KARYOPHARM THERAPEUTICS TO INITIATE NEW GLOBAL CLINICAL TRIAL TO TREAT PATIENTS WITH COVID-19 — First Study of an XPO1 Inhibitor to Treat Patients with Severe Viral Infections — Precision for Medicine Responsible for Clinical Trial Management in Europe BUDAPEST, April 22, 2020 – Precision for […]
April 2, 2020

EVICTION Trial to Evaluate Anti-cancer Drug ICT01 Launches

First-in-human, international, multi-center trial to test Butyrophylin 3A-targeted antibody in advanced solid and hematologic tumors – Precision provides global central lab support and US site management Marseille, France, March 26, 2020 – ImCheck Therapeutics announced today that it has dosed the first patient in a Phase I/IIa clinical trial evaluating […]
January 27, 2020

Precision For Medicine Taps Mairead Kehoe as Executive Vice President, Clinical Solutions

VETERAN STRATEGIST AND LEADER TO GUIDE THE CONTINUED EXPANSION AND GROWTH OF PRECISION’S INDUSTRY-LEADING GLOBAL CLINICAL TRIALS SOLUTIONS   January 27, 2020– New York, NY – Precision for Medicine, the first comprehensive, fully-integrated biomarker-driven clinical research services organization, today announced that veteran healthcare leader Mairead Kehoe has been named its […]
December 5, 2019

Precision for Medicine, Oncology and Rare Disease Named Best Specialist CRO By OBN Awards

PRECISION’S UNIQUE COMBINATION OF CLINICAL SERVICES AND TRANSLATIONAL SCIENCES IS RECOGNISED FOR BIOTECH INDUSTRY INNOVATION   5 December, 2019 – London, UK – Precision for Medicine, Oncology and Rare Disease, the first comprehensive, fully integrated CRO devoted to oncology and rare disease innovation, announced its recognition as Best Specialist CRO […]
November 27, 2019

Precision for Medicine Significantly Expands Berlin Lab as Demand For Immune Monitoring Continues to Grow

NEW STATE-OF-THE-ART FACILITY DRAMATICALLY INCREASES CAPACITY FOR CLINICAL TRIALS AND OFFERS CLIENTS FIRST-OF-ITS-KIND CELL PROFILING CAPABILITIES COMBINING EPIGENETICS AND FLOW CYTOMETRY   BERLIN, GERMANY – 27 NOVEMBER 2019 – Precision for Medicine, part of Precision Medicine Group, today announced that they have opened a new 1,600 m2 Berlin-based laboratory, for […]